{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:52:22Z","timestamp":1690530742863},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"DOI":"10.2146\/ajhp110562","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T06:01:30Z","timestamp":1351663290000},"page":"1895-1904","source":"Crossref","is-referenced-by-count":7,"title":["National survey on continuous and extended infusions of antibiotics"],"prefix":"10.1093","volume":"69","author":[{"given":"Jomy M.","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Colton","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Pharmacy Administration, University of the Sciences in Philadelphia, Philadelphia, PA. benjamin j. colton, Pharm.D., BCPS, is Infectious Diseases Clinical Specialist, Department of Pharmacy, Resurrection Health Care, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Rodvold","sequence":"additional","affiliation":[{"name":"Colleges of Pharmacy and Medicine, University of Illinois at Chicago, Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041204024209200_b1-0691895","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jac\/5.5.503","article-title":"Optimal dosage regimen for penicillins: bolus or continuous infusion?","volume":"5","author":"Curcio","year":"1979","journal-title":"J Antimicrob Chemother"},{"key":"2019041204024209200_b2-0691895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2019041204024209200_b3-0691895","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2165\/00003495-200565170-00006","article-title":"Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters","volume":"65","author":"Kasiakou","year":"2005","journal-title":"Drugs"},{"key":"2019041204024209200_b4-0691895","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0149-2918(02)80021-2","article-title":"Pharmacokinetics and pharmacodynamics of piperacillin\/tazobactam when administered by continuous infusion and intermittent dosing","volume":"24","author":"Burgess","year":"2002","journal-title":"Clin Ther"},{"key":"2019041204024209200_b5-0691895","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2007.02.002","article-title":"Continuous infusion of \u03b2-lactam antibiotics in severe infections: a review of its role","volume":"30","author":"Roberts","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"2019041204024209200_b6-0691895","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MCC.0b013e3283021b3a","article-title":"Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?","volume":"14","author":"Roberts","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"2019041204024209200_b7-0691895","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1345\/aph.1M717","article-title":"High-dose continuous infusion \u03b2-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients","volume":"44","author":"Moriyama","year":"2010","journal-title":"Ann Pharmacother"},{"key":"2019041204024209200_b8-0691895","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2146\/ajhp050323","article-title":"Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infections","volume":"63","author":"DeRyke","year":"2006","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041204024209200_b9-0691895","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijantimicag.2008.09.012","article-title":"Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii","volume":"33","author":"Wang","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"2019041204024209200_b10-0691895","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1592\/phco.22.7.471.33665","article-title":"Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital","volume":"22","author":"Grant","year":"2002","journal-title":"Pharmacotherapy"},{"key":"2019041204024209200_b11-0691895","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00019048-199905000-00008","article-title":"Pharmacokinetic and economic evaluation of piperacillin\/tazobactam administered as either continuous or intermittent infusion with once-daily gentamicin","volume":"8","author":"Richerson","year":"1999","journal-title":"Infect Dis Clin Pract"},{"key":"2019041204024209200_b12-0691895","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","article-title":"Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy","volume":"44","author":"Lodise","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019041204024209200_b13-0691895","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/313692","article-title":"National survey of extended-interval aminoglycoside dosing","volume":"30","author":"Chuck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2019041204024209200_b14-0691895","unstructured":"Society of Infectious Diseases Pharmacists. What is SIDP?www.sidp.org (accessed 2011 Jun 6)."},{"key":"2019041204024209200_b15-0691895","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"2019041204024209200_b16-0691895","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.86.5.726","article-title":"Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods","volume":"86","author":"Aickin","year":"1996","journal-title":"Am J Public Health"},{"key":"2019041204024209200_b17-0691895","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989","volume":"91","author":"Banerjee","year":"1991","journal-title":"Am J Med"},{"key":"2019041204024209200_b18-0691895","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1592\/phco.31.8.767","article-title":"The Retrospective Cohort of Extended-Infusion Piperacillin- Tazobactam (RECEIPT) study: a multicenter study","volume":"31","author":"Yost","year":"2011","journal-title":"Pharmacotherapy"},{"key":"2019041204024209200_b19-0691895","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(05)70218-8","article-title":"Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials","volume":"5","author":"Kasiakou","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"2019041204024209200_b20-0691895","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit Care Med"},{"key":"2019041204024209200_b21-0691895","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5414\/CPP43360","article-title":"Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen","volume":"43","author":"Georges","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2019041204024209200_b22-0691895","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0149-2918(00)87978-3","article-title":"Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion","volume":"22","author":"Burgess","year":"2000","journal-title":"Clin Ther"},{"key":"2019041204024209200_b23-0691895","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0924-8579(01)00329-6","article-title":"Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia","volume":"17","author":"Nicolau","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"2019041204024209200_b24-0691895","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/AAC.00329-06","article-title":"Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intraabdominal infection","volume":"50","author":"Lau","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041204024209200_b25-0691895","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9610(00)00388-3","article-title":"Intermittent and continuous ceftazidime infusion for critically ill trauma patients","volume":"179","author":"Hanes","year":"2000","journal-title":"Am J Surg"},{"key":"2019041204024209200_b26-0691895","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.40.3.696","article-title":"Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections","volume":"40","author":"James","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041204024209200_b27-0691895","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.45.9.2460-2467.2001","article-title":"Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study","volume":"45","author":"Wysocki","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041204024209200_b28-0691895","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2000.00179.x","article-title":"Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis","volume":"50","author":"Angus","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"2019041204024209200_b29-0691895","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/AAC.41.4.733","article-title":"Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion","volume":"41","author":"Mouton","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041204024209200_b30-0691895","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1211\/002235702171","article-title":"Continuous infusion versus intermittent administration of cefepime in patients with gram-negative bacilli bacteraemia","volume":"54","author":"Jaruratanasirikul","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"2019041204024209200_b31-0691895","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/AAC.38.5.931","article-title":"Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model","volume":"38","author":"Mouton","year":"1994","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/21\/1895\/28361999\/ajhp1895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:06:41Z","timestamp":1555114001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/21\/1895\/5112127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":31,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110562","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,11,1]]},"published":{"date-parts":[[2012,11,1]]}}}